{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:26:02Z","timestamp":1780334762355,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jaip.2020.02.031","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T21:54:26Z","timestamp":1583445266000},"page":"2608-2614.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0421-6610","authenticated-orcid":false,"given":"Florian","family":"Gothe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessa","family":"Schmautz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"H\u00e4usler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen-Binh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kappler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Griese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.02.031_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.02.031_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nm.2715","article-title":"Cystic fibrosis: a mucosal immunodeficiency syndrome","volume":"18","author":"Cohen","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2020.02.031_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1164\/rccm.200710-1599OC","article-title":"Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis","volume":"178","author":"Kozlowska","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.02.031_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ppul.21525","article-title":"Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis","volume":"47","author":"Mayer-Hamblett","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaip.2020.02.031_bib5","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/cea.12595","article-title":"Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis","volume":"45","author":"Maturu","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.02.031_bib6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/archinte.1986.00360170130020","article-title":"Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies","volume":"146","author":"Patterson","year":"1986","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2020.02.031_bib7","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jaip.2017.03.033","article-title":"Increasing total serum IgE, allergic bronchopulmonary aspergillosis, and lung function in cystic fibrosis","volume":"5","author":"Gothe","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.02.031_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2013.04.007","article-title":"Novel immunologic classification of aspergillosis in adult cystic fibrosis","volume":"132","author":"Baxter","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.031_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1183\/13993003.01068-2015","article-title":"Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"47","author":"Gernez","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.02.031_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1542\/peds.87.2.245","article-title":"Risks of alternate-day prednisone in patients with cystic fibrosis","volume":"87","author":"Rosenstein","year":"1991","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2020.02.031_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0022-3476(98)70172-6","article-title":"Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study","volume":"133","author":"Bhudhikanok","year":"1998","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2020.02.031_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A\u00a0randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.02.031_bib13","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2014State of the Art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2020.02.031_bib14","first-page":"CD002204","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","volume":"11","author":"Elphick","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2020.02.031_bib15","first-page":"513","article-title":"Flow resistance of airways and pulmonary flow resistance in children and juveniles: normal values and their significance for the evaluation of airway obstruction [in Czech]","volume":"32","author":"Zapletal","year":"1977","journal-title":"Ces Pediatr"},{"key":"10.1016\/j.jaip.2020.02.031_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaip.2020.02.031_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1055\/s-0030-1253666","article-title":"Percentiles of body mass index of 18-80-year-old German adults based on data from the Second National Nutrition Survey [in German]","volume":"135","author":"Hemmelmann","year":"2010","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jaip.2020.02.031_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ejcn.2010.8","article-title":"Body mass index percentiles for children and adolescents in Germany based on a nationally representative sample (KiGGS 2003-2006)","volume":"64","author":"Rosario","year":"2010","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jaip.2020.02.031_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1378\/chest.115.2.364","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole","volume":"115","author":"Nepomuceno","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2020.02.031_bib20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1164\/rccm.200603-423OC","article-title":"Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis","volume":"174","author":"Kraemer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.02.031_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/ciw444","article-title":"Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2020.02.031_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/mmy\/myy014","article-title":"The diagnosis and management of respiratory tract fungal infection in cystic fibrosis: a UK survey of current practice","volume":"57","author":"Boyle","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.jaip.2020.02.031_bib23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.chest.2018.01.005","article-title":"A\u00a0randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"153","author":"Agarwal","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2020.02.031_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jaci.2005.09.023","article-title":"Pulmonary TH2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis","volume":"117","author":"Hartl","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.031_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/thx.54.1.44","article-title":"Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA)","volume":"54","author":"Skov","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.02.031_bib26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/jcm.32.2.525-527.1994","article-title":"Suppression of fungal growth exhibited by Pseudomonas aeruginosa","volume":"32","author":"Kerr","year":"1994","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jaip.2020.02.031_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0134692","article-title":"Inhibition of Aspergillus fumigatus and its biofilm by Pseudomonas aeruginosa is dependent on the source, phenotype and growth conditions of the bacterium","volume":"10","author":"Ferreira","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2020.02.031_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1574-6968.2010.02130.x","article-title":"Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation","volume":"313","author":"Mowat","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jaip.2020.02.031_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JB.00345-17","article-title":"Studies of Pseudomonas aeruginosa mutants indicate pyoverdine as the central factor in inhibition of Aspergillus fumigatus biofilm","volume":"200","author":"Sass","year":"2018","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.jaip.2020.02.031_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1439-0507.1999.00505.x","article-title":"Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole","volume":"42","author":"Glasmacher","year":"1999","journal-title":"Mycoses"},{"key":"10.1016\/j.jaip.2020.02.031_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1439-0507.1989.tb02299.x","article-title":"Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels","volume":"32","author":"Boogaerts","year":"1989","journal-title":"Mycoses"},{"key":"10.1016\/j.jaip.2020.02.031_bib32","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820301926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820301926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:22:45Z","timestamp":1761974565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820301926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2213219820301926"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.02.031","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}